Form 144 shows planned sale of 6,057 Class A shares

A holder has filed a notice to sell 6,057 Class A Ordinary shares under Rule 144 through UBS Financial Services, Inc. on the NYSE, with an aggregate market value of 1,461,101.64.

Rhea-AI Filing Summary

A holder has filed a notice to sell 6,057 Class A Ordinary shares under Rule 144 through UBS Financial Services, Inc. on the NYSE, with an aggregate market value of 1,461,101.64. The issuer has 660,432,542 shares outstanding.

The shares to be sold were acquired as a stock award from the issuer on 02/01/2026. The filer, identified in recent sales as Julie Sweet, has sold additional Class A Ordinary shares in the past three months, including 5,500 shares on 02/03/2026 and 1,694 shares on 01/14/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing for ACN indicate about upcoming share sales?

This Form 144 shows an intent to sell 6,057 Class A Ordinary shares on the NYSE. The planned sale, with an aggregate market value of 1,461,101.64, is being made under Rule 144, which governs resales of restricted and control securities.

Who is selling shares in the ACN-related Form 144 and how many?

The filing reflects sales for the account of Julie Sweet, involving 6,057 Class A Ordinary shares. These shares were acquired as a stock award on 02/01/2026, and are scheduled to be sold through UBS Financial Services on the NYSE.

What prior ACN share sales are disclosed in this Form 144 notice?

The notice lists two recent sales by Julie Sweet: 5,500 Class A Ordinary shares sold on 02/03/2026 for 1,333,120.80 and 1,694 shares sold on 01/14/2026 for 488,380.20, all in the same class of stock.

How were the ACN shares in this Form 144 acquired by the seller?

The 6,057 Class A Ordinary shares covered by this notice were acquired via a stock award from the issuer on 02/01/2026. The filing states the securities came directly from the issuer rather than a purchase in the open market.

What is the share count and market value context in this ACN Form 144?

The filer plans to sell 6,057 Class A Ordinary shares with an aggregate market value of 1,461,101.64. The issuer has 660,432,542 shares outstanding, providing context for the relative size of the intended Rule 144 sale.

Which broker and exchange are involved in the planned ACN share sale?

The planned sale of 6,057 Class A Ordinary shares will be executed through UBS Financial Services, Inc., located in New York. The securities are listed for trading on the NYSE, which is the named securities exchange in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001487630
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Accenture plc
SEC File Number	001-34448
Address of Issuer	1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN IRELAND D2
Phone	353-1-646-2000
Name of Person for Whose Account the Securities are To Be Sold	Sweet Julie Spellman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	6057	1461101.64	660432542	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	02/01/2026	Stock Award	Issuer			6057	02/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Julie Sweet 1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN L2 D2	Class A Ordinary	02/03/2026	5500	1333120.80
Julie Sweet 1 GRAND CANAL SQUARE GRAND CANAL HARBOUR Dublin L2 L2	Class A Ordinary	01/14/2026	1694	488380.20

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Julie Sweet
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)